Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis

Table 3 Sensitivity analysis of all 7 studies

Deleted study	No. of patients after deletion	Odds ratio		Model	Heterogeneity
Deleted study	No. of patients after deletion	OR (95% CI)	P value	Model	I²	P
Hanako Suzuki 2011 [24]	479	1.40 (0.73, 2.69)	0.02	Random	61%	0.02
Juan Li 2017 [25]	437	2.14 [1.45, 3.15]	0.0001	Fixed	28%	0.23
Kyuichi Kadota 2010 [20]	469	1.74 [0.99, 3.06]	0.05	Random	47%	0.09
Shotaro Iwakiri 2009	437	1.54 [0.77, 3.08]	0.22	Random	62%	0.02
Takeo Ito 2019 [26]	383	1.25 [0.54, 2.87]	0.61	Random	61%	0.03
Yoichiro IKOMA 2015 [27]	416	1.21 [0.57, 2.60]	0.62	Random	57%	0.04
Yoshihisa Shimada 2009 [28]	357	1.30 [0.58, 2.89]	0.52	Random	63%	0.02

ISSN: 1471-2407